Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme

A new series of co-drugs was designed based on hybridising the dihydropteroate synthase (DHPS) inhibitor sulphonamide scaffold with the COX-2 inhibitor salicylamide pharmacophore through biodegradable linkage to achieve compounds with synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme to...

Full description

Bibliographic Details
Main Authors: Nada H. El-Dershaby, Soad A. El-Hawash, Shaymaa E. Kassab, Hoda G. Dabees, Ahmed E. Abdel Moneim, Ibrahim A. Abdel Wahab, Mohammad M. Abd-Alhaseeb, Mostafa M. M. El-Miligy
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2022.2086868
_version_ 1818553061279268864
author Nada H. El-Dershaby
Soad A. El-Hawash
Shaymaa E. Kassab
Hoda G. Dabees
Ahmed E. Abdel Moneim
Ibrahim A. Abdel Wahab
Mohammad M. Abd-Alhaseeb
Mostafa M. M. El-Miligy
author_facet Nada H. El-Dershaby
Soad A. El-Hawash
Shaymaa E. Kassab
Hoda G. Dabees
Ahmed E. Abdel Moneim
Ibrahim A. Abdel Wahab
Mohammad M. Abd-Alhaseeb
Mostafa M. M. El-Miligy
author_sort Nada H. El-Dershaby
collection DOAJ
description A new series of co-drugs was designed based on hybridising the dihydropteroate synthase (DHPS) inhibitor sulphonamide scaffold with the COX-2 inhibitor salicylamide pharmacophore through biodegradable linkage to achieve compounds with synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme to enhance antibacterial activity for treatment of septicaemia. Compounds 5 b, 5j, 5n and 5o demonstrated potent in vitro COX-2 inhibitory activity comparable to celecoxib. 5j and 5o exhibited ED50 lower than celecoxib in carrageenan-induced paw edoema test with % PGE2 inhibition higher than celecoxib. Furthermore, 5 b, 5j and 5n showed gastric safety profile like celecoxib. Moreover, in vivo antibacterial screening revealed that, 5j showed activity against S.aureus and E.coli higher than sulfasalazine. While, 5o revealed activity against E.coli higher than sulfasalazine and against S.aureus comparable to sulfasalazine. Compound 5j achieved the target goal as potent inhibitor of COX-2/PGE2 axis and in vivo broad-spectrum antibacterial activity against induced septicaemia in mice.
first_indexed 2024-12-12T09:21:07Z
format Article
id doaj.art-09f1914e14b8496fbcf7c84b641248cb
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-12-12T09:21:07Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-09f1914e14b8496fbcf7c84b641248cb2022-12-22T00:29:12ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742022-12-013711737175110.1080/14756366.2022.2086868Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzymeNada H. El-Dershaby0Soad A. El-Hawash1Shaymaa E. Kassab2Hoda G. Dabees3Ahmed E. Abdel Moneim4Ibrahim A. Abdel Wahab5Mohammad M. Abd-Alhaseeb6Mostafa M. M. El-Miligy7Pharmaceutical Chemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour, EgyptPharmaceutical Chemistry Department, Faculty of Pharmacy, Alexandria University, Alexandria, EgyptPharmaceutical Chemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour, EgyptPharmaceutical Chemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour, EgyptDepartment of Zoology and Entomology, Faculty of Science, Helwan University, Cairo, EgyptMicrobiology and Immunology Department, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhur University, Damanhour, EgyptPharmaceutical Chemistry Department, Faculty of Pharmacy, Alexandria University, Alexandria, EgyptA new series of co-drugs was designed based on hybridising the dihydropteroate synthase (DHPS) inhibitor sulphonamide scaffold with the COX-2 inhibitor salicylamide pharmacophore through biodegradable linkage to achieve compounds with synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme to enhance antibacterial activity for treatment of septicaemia. Compounds 5 b, 5j, 5n and 5o demonstrated potent in vitro COX-2 inhibitory activity comparable to celecoxib. 5j and 5o exhibited ED50 lower than celecoxib in carrageenan-induced paw edoema test with % PGE2 inhibition higher than celecoxib. Furthermore, 5 b, 5j and 5n showed gastric safety profile like celecoxib. Moreover, in vivo antibacterial screening revealed that, 5j showed activity against S.aureus and E.coli higher than sulfasalazine. While, 5o revealed activity against E.coli higher than sulfasalazine and against S.aureus comparable to sulfasalazine. Compound 5j achieved the target goal as potent inhibitor of COX-2/PGE2 axis and in vivo broad-spectrum antibacterial activity against induced septicaemia in mice.https://www.tandfonline.com/doi/10.1080/14756366.2022.2086868SulphonamidessalicylamidesCOX-2 inhibitorsPGE2septicaemia
spellingShingle Nada H. El-Dershaby
Soad A. El-Hawash
Shaymaa E. Kassab
Hoda G. Dabees
Ahmed E. Abdel Moneim
Ibrahim A. Abdel Wahab
Mohammad M. Abd-Alhaseeb
Mostafa M. M. El-Miligy
Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme
Journal of Enzyme Inhibition and Medicinal Chemistry
Sulphonamides
salicylamides
COX-2 inhibitors
PGE2
septicaemia
title Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme
title_full Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme
title_fullStr Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme
title_full_unstemmed Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme
title_short Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme
title_sort rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of cox 2 pge2 axis and dhps enzyme
topic Sulphonamides
salicylamides
COX-2 inhibitors
PGE2
septicaemia
url https://www.tandfonline.com/doi/10.1080/14756366.2022.2086868
work_keys_str_mv AT nadaheldershaby rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme
AT soadaelhawash rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme
AT shaymaaekassab rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme
AT hodagdabees rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme
AT ahmedeabdelmoneim rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme
AT ibrahimaabdelwahab rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme
AT mohammadmabdalhaseeb rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme
AT mostafammelmiligy rationaldesignofbiodegradablesulphonamidecandidatestreatingsepticaemiabysynergisticdualinhibitionofcox2pge2axisanddhpsenzyme